The economic impact of compassionate use of medicines

BACKGROUND: Compassionate use programs (CUP) for medicines respond to the ethical imperative of providing access to medicines before marketing approval to patients not recruited in trials. The economic impact of clinical trials has previously been investigated. No evidence on the net economic benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jommi, Claudio, Pantellini, Federico, Stagi, Lisa, Verykiou, Maria, Cavazza, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645125/
https://www.ncbi.nlm.nih.gov/pubmed/34863155
http://dx.doi.org/10.1186/s12913-021-07255-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645125/
https://www.ncbi.nlm.nih.gov/pubmed/34863155
http://dx.doi.org/10.1186/s12913-021-07255-w

Ejemplares similares